Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Tocilizumab for Prophylaxis of Cytokine Release Syndrome after Outpatient-Based Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation

Oscar Marquez, MD, Andrés Gómez-De León, MD, Perla R. Colunga Pedraza, MD, Cesar O Pezina Cantú, MD, Diana E Garcia-Camarillo, MD, Paola Santana-Hernandez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 5624.

https://doi.org/10.1182/blood-2019-132088

Published: 2019

Journal Articles

Cytokine Release Syndrome after Peripheral Blood T-Cell Replete Haploidentical Transplantation Is Not Prevented By Dexamethasone and Limits Its Full-Outpatient Conduction

Perla R. Colunga Pedraza, MD, Andrés Gómez-De León, MD, Julia Esther Colunga Pedraza, MD, Emmanuel Bugarin Estrada, MD, Paola Santana-Hernandez, MD, Olga Cantu Rodriguez, MD, Cesar Homero Gutierrez Aguirre, MD, Luz del Carmen Tarín Arzaga, MD, José Miguel Yañez Reyes, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 3355.

https://doi.org/10.1182/blood-2018-99-116996

Published: 2018

Journal Articles

Donor Lymphocyte Infusion from G-CSF-Primed, Unmanipulated Whole Blood Is Safe and Improves Chimerism in HLA-Matched and Haploidentical Transplantation

Andrés Gómez-De León, MD, Perla R Colunga Pedraza, MD, Diana E Garcia-Camarillo, MD, Roberto I. Vázquez-Garza, MD, Paola Santana-Hernandez, MD, Cesar Homero Gutierrez Aguirre, MD, Olga Cantu Rodriguez, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 4602.

https://doi.org/10.1182/blood-2018-99-115420

Published: 2018

Journal Articles

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

Cesar O Pezina Cantú, MD, Perla R. Colunga Pedraza, MD, Andres Gomez De Leon, MD, Diana E Garcia-Camarillo, MD, Oscar Marquez-Pinedo, MD, Paola Santana-Hernandez, MD, Olga Cantu Rodriguez, MD, Cesar Homero Gutierrez Aguirre, MD, Luz del Carmen Tarín Arzaga, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 1043.

https://doi.org/10.1182/blood-2018-99-118611

Published: 2018

Journal Articles

Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report

Paola Santana-Hernandez, Perla Rocio Colunga Pedraza, MD, Guillermo Sotomayor Duque, MD, Andrés Gómez-De León, MD, Luz del Carmen Tarín Arzaga, MD, Cesar Homero Gutierrez Aguirre, Olga Cantu Rodriguez, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 5254.

https://doi.org/10.1182/blood.V130.Suppl_1.5254.5254

Published: 2017

Journal Articles

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Perla Rocio Colunga Pedraza, MD, Andres Gomez De Leon, MD, Guillermo Sotomayor Duque, MD, Julia Esther Colunga Pedraza, MD, Yadith Karina López García, Paola Santana-Hernandez, Cesar Homero Gutierrez Aguirre, Olga Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Oscar Gonzalez Llano, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 1940.

https://doi.org/10.1182/blood.V130.Suppl_1.1940.1940

Published: 2017

Journal Articles

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

David Gomez-Almaguer, MD, Olga Cantu-Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, MD, Jose Carlos Jaime-Perez, MD PhD, Luz C. Tarin-Arzaga, MD, Monica Sanchez Cardenas, MD, Rosa Elena Lozano-Morales, MD, Guillermo Sotomayor Duque, MD, Daniela Cárdenas-Araujo, MD, Andres Gomez-de Leon, MD, Paola Santana-Hernandez, Perla Rocío Colunga-Pedraza, MD

Blood (2016) 128 (22): 1369.

https://doi.org/10.1182/blood.V128.22.1369.1369

Published: 2016

NARROW

Tocilizumab for Prophylaxis of Cytokine Release Syndrome after Outpatient-Based Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation

Cytokine Release Syndrome after Peripheral Blood T-Cell Replete Haploidentical Transplantation Is Not Prevented By Dexamethasone and Limits Its Full-Outpatient Conduction

Donor Lymphocyte Infusion from G-CSF-Primed, Unmanipulated Whole Blood Is Safe and Improves Chimerism in HLA-Matched and Haploidentical Transplantation

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

Email alerts

ASH Publications

American Society of Hematology

Tocilizumab for Prophylaxis of Cytokine Release Syndrome after Outpatient-Based Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation

Cytokine Release Syndrome after Peripheral Blood T-Cell Replete Haploidentical Transplantation Is Not Prevented By Dexamethasone and Limits Its Full-Outpatient Conduction

Donor Lymphocyte Infusion from G-CSF-Primed, Unmanipulated Whole Blood Is Safe and Improves Chimerism in HLA-Matched and Haploidentical Transplantation

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only